Key Development
A nearly VND 170 billion hospital investment in Hue has exposed a fundamental weakness in healthcare infrastructure development: physical capacity can be built long before an institution develops the operational capability to use it.
Chan May General Hospital, designed for 200 beds and operational since 2015, has never fully utilized its intended capacity. Inspection findings identified 35 medical devices accepted and paid for but never put into use, while 29 of the project’s 54 procurement packages lacked sufficient documentation for final settlement.
Some equipment, including ventilators, dialysis machines and neonatal incubators, has reportedly become unusable or technologically outdated. Authorities have referred findings involving procurement and construction irregularities to investigators, while Hue is considering transferring hospital operations to Hue University of Medicine and Pharmacy Hospital.
The larger issue is not simply unused equipment.
It is the widening gap between healthcare capital expenditure and actual clinical capacity.
Why It Matters
- Healthcare investment is not equivalent to healthcare delivery. Buildings and equipment create potential capacity, not guaranteed patient services.
- Idle medical technology represents depreciating capital, particularly when assets become obsolete before clinical deployment.
- Hospital utilization is fundamentally a demand-and-execution problem, requiring patient flows, specialists and sustainable service delivery.
- Institutional restructuring may become an alternative to new construction, particularly where existing public assets remain underperforming.
- Capital productivity should become a central healthcare investment KPI, alongside infrastructure expansion and procurement completion.
Healthcare Insight Analysis
Healthcare Insight believes the Chan May case illustrates a structural problem in hospital investment:
Vietnam may need to focus less on how much healthcare infrastructure it builds and more on how effectively that infrastructure is activated.
Hospital capacity is created through a sequence of interconnected investments.
Infrastructure must be completed.
Medical equipment must be clinically operational.
Qualified professionals must be available.
Patients must have reasons to use the facility.
Clinical activity must generate sustainable operating value.
If any part of this sequence breaks down, capital remains trapped in assets that deliver limited healthcare benefits.
Capital investment → clinical readiness → patient utilization → service productivity → sustainable value.
This is the economic chain that should determine hospital investment performance.
The Chan May experience demonstrates what happens when procurement completion does not translate into clinical utilization.
Medical devices are particularly vulnerable.
Unlike conventional infrastructure, advanced medical technology has a limited useful life shaped by software updates, maintenance requirements, regulatory standards and clinical innovation.
A machine that remains unused for years can lose much of its productive value without ever generating clinical returns.
For healthcare executives, this changes the investment question.
It is not merely:
Can the institution afford to purchase the equipment?
It is:
Can the institution consistently operate the equipment at sufficient clinical volume to justify its total lifecycle cost?
The proposed transfer to a university-affiliated hospital adds another strategic dimension.
Instead of establishing an entirely new operating structure, integration with an existing clinical institution could provide access to specialist resources, stronger clinical governance and established management capabilities.
However, changing the operator does not automatically create patient demand.
Without an assessment of catchment-area demographics, referral networks, workforce availability and viable clinical specialties, the same assets may continue to underperform under new management.
This is why hospital restructuring should begin with clinical and financial feasibility, not administrative consolidation alone.
The more important opportunity is to rethink how healthcare assets are evaluated.
An installed hospital bed is not the same as an occupied bed.
A purchased medical device is not the same as a functioning clinical service.
A completed hospital project is not the same as a productive healthcare institution.
These distinctions should shape capital allocation across Vietnam’s healthcare ecosystem.
Market Implications
Public hospital operators: need stronger demand forecasting, clinical service planning and measurable asset-utilization targets before undertaking major capital projects.
Medical device companies: face growing incentives to provide lifecycle services, maintenance, clinical training and utilization support rather than relying solely on equipment sales.
University-affiliated hospitals: may find opportunities to expand their operating networks through integration with underutilized facilities, provided clinical and financial feasibility can be demonstrated.
Healthcare investors: should evaluate existing hospitals using operating indicators such as patient volumes, bed occupancy, equipment utilization and sustainable service economics.
Policymakers: have an opportunity to strengthen post-investment accountability by connecting capital expenditure with measurable healthcare delivery outcomes.
ANALYTICAL MATRIX
| Dimension | Current Signal | Opportunity | Key Risk |
| Infrastructure | Nearly VND 170bn invested | Recover existing asset value | Persistent underutilization |
| Medical equipment | 35 devices unused | Lifecycle-based procurement | Technology obsolescence |
| Hospital capacity | 200-bed design | Optimize clinical services | Insufficient patient demand |
| Operating model | Proposed university-hospital transfer | Clinical integration | Weak execution |
| Capital governance | 29 procurement packages with insufficient settlement records | Stronger investment oversight | Financial and legal exposure |
Vietnam does not simply need more hospital infrastructure. It needs more productive hospital infrastructure.
The Chan May case points to a broader investment reality: healthcare capacity only creates economic and social value when assets, clinical capabilities and patient demand operate together.
For hospital leaders, medical technology suppliers and healthcare investors, the next competitive advantage may not come from building more facilities.
It may come from turning existing healthcare assets into measurable clinical productivity.
And that requires a fundamental shift:
from infrastructure expansion toward healthcare capital efficiency.